According to ImmunoGen 's latest financial reports the company's current revenue (TTM ) is C$0.40 Billion. In 2022 the company made a revenue of C$0.14 Billion an increase over the revenue in the year 2021 that were of C$89.02 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.